New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Avicanna Inc.
AVCN.TO
Shape
US Flag

TSX

Unprofitable

Unprofitable

36M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

36M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

0.37CAD
Shape-0.01 ( -1.33%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

396%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

38%

Quote Panel

Shape
Updated October 6, 2024
1W -2.63 % 1M -1.33 % 3M -2.63 % 1Y -21.28 %

Key Metrics

Shape
  • Market Cap

    35.86M


  • Shares Outstanding

    98.24M


  • Share in Float

    78.14M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.37


  • Average Volume

    126666


  • Beta

    1.309


  • Range

    0.2-0.6


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.avicanna.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.44x

P/S Ratio

1019.90x

P/B Ratio

46.1

Debt/Equity

-26.3%

Net Margin

$-0.1

EPS

How AVCN.TO compares to sector?

P/E Ratio

Relative Strength

Shape

AVCN.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$25M

Shape312%

2025-Revenue

$0.07

Shape472%

2025-EPS

$22M

Shape-1349%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.02
vs -0.09

Q2.22

arrow
arrow

N/A

-0.11
vs -0.07

Q3.22

arrow
arrow

N/A

-0.05
vs -0.06

Q4.22

arrow
arrow

N/A

-0.10
vs -0.18

Q1.23

arrow
arrow

N/A

-0.03
vs -0.02

Q2.23

arrow
arrow

N/A

-0.02
vs -0.11

Q3.23

arrow
arrow

N/A

-0.02
vs -0.05

Q4.23

arrow
arrow

N/A

-0.03
vs -0.10

Q1.24

arrow
arrow

N/A

-0.01
vs -0.03

Q2.24

arrow
arrow

N/A

-0.02
vs -0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

+283%

1M  vs 270.9K

Q2.22

arrow
arrow

+39%

1.1M  vs 792.2K

Q3.22

arrow
arrow

-22%

771.3K  vs 988K

Q4.22

arrow
arrow

-7%

1.1M  vs 1.2M

Q1.23

arrow
arrow

+13%

1.2M  vs 1M

Q2.23

arrow
arrow

+201%

3.3M  vs 1.1M

Q3.23

arrow
arrow

+711%

6.3M  vs 771.3K

Q4.23

arrow
arrow

+433%

6.1M  vs 1.1M

Q1.24

arrow
arrow

+451%

6.4M  vs 1.2M

Q2.24

arrow
arrow

+85%

6.1M  vs 3.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-114%

-1.14
vs -2.38

Q4.22

arrow
arrow

+1955%

19.55
vs -1.14

Q1.23

arrow
arrow

-211%

-2.11
vs 19.55

Q2.23

arrow
arrow

-129%

-1.29
vs -2.11

Q3.23

arrow
arrow

-139%

-1.39
vs -1.29

Q4.23

arrow
arrow

+2291%

22.91
vs -1.39

Q1.24

arrow
arrow

+154%

1.54
vs 22.91

Q2.24

arrow
arrow

-5174%

-51.74
vs 1.54

Institutionnal OwnershipShape

status-upQoQ

Q2.21

arrow
arrow

1

1
vs NA

NA

Q2.23

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News